Research Training Core

研究培训/教育核心将在我国首都健康差距卓越中心为少数群体健康和健康差距研究教育和培训提供一个单一的综合之家。核心的产品将涵盖乔治敦大学（GU）和霍华德大学（HU）现有的教育和培训计划，以及CEHD将开发的新计划。 背景 显然有必要增加临床调查人员的人数，这些人受过必要的培训，能够在诊断和治疗影响城市少数群体和贫困人口的疾病方面进行研究。GU，HU和其他CEHD合作者提供大部分的机构医疗，神经，精神，高危产科和康复医学护理;卫生专业的研究生教育;和临床培训在哥伦比亚特区（DC）。因此，这些机构拥有与DC社区的广泛接触和紧密联系，促进跨学科培训和临床研究机会。每个机构都为CEHD带来互补的优势和兴趣，并将加强努力招募代表性不足的少数民族，妇女和残疾人参加临床研究培训。CEHD内的研究培训和教育将通过GU和HU强大的转化和基础科学计划得到加强，特别是在临床和基础药理学，神经科学，癌症，分子遗传学，酗酒和药物滥用以及药物发现方面。MedStar Health在设计和协调大型多中心观察性研究，干预试验和社区参与性研究方面具有优势，特别是在糖尿病和心血管疾病方面，以及专注于残疾，康复和急性后护理的研究。

The Research Training/Education Core will provide a single integrated home for minority health and health disparities research education and training in the Center of Excellence for Health Disparities in our Nation's Capital (CEHD). The core's offerings will span the existing education and training programs at Georgetown University (GU) and Howard University (HU) and the new programs that the CEHD will develop. BACKGROUND A clear need exists to increase the number of clinical investigators who have the training necessary to conduct research in diagnosing and treating diseases that affect urban minority and poor populations. GU, HU, and the other CEHD collaborators provide most of the institutional medical, neurologic, psychiatric, high-risk obstetric,and rehabilitation medicine care; health professions' graduate education; and clinical training in the District of Columbia (DC). Thus, these institutions possess broad access to and strong ties with the DC community that facilitate for cross-disciplinary training and opportunities for clinical investigation. Each institution brings complementary strengths and interests to the CEHD and will enhance efforts to recruit underrepresented minorities, women, and people with disabilities to clinical research training. Research training and education within the CEHD will be enhanced through the strong translational and basic science programs at GU and HU, especially in clinical and basic pharmacology, neuroscience, cancer, molecular genetics, alcoholism and drug abuse, and drug discovery. MedStar Health brings strengths in the design and coordination of large multicenter observational studies, intervention trials, and community participatory research, particularly in diabetes and cardiovascular disease, as well as research focused on disabilities, rehabilitation, and post-acute care.